Stevanato Group (STVN) Q3 Earnings and Revenues Surpass EstimatesZacks Investment Research • 11/06/25
Stevanato Group Reports Revenue of €303.2 Million for the Third Quarter of 2025Business Wire • 11/06/25
Stevanato Group to Report Third Quarter 2025 Financial Results on November 6, 2025Business Wire • 10/22/25
Stevanato Group Expands Drug Delivery Systems Capacity to Strengthen Global Integrated OfferingsBusiness Wire • 10/21/25
Stevanato Group S.p.A. (STVN) Presents at Bank of America Global Healthcare Conference 2025 TranscriptSeeking Alpha • 09/24/25
Stevanato Group S.p.A. (STVN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/09/25
Stevanato Group Reports Revenue of €280.0 Million for the Second Quarter of 2025Business Wire • 08/05/25
Stevanato Group (STVN) Earnings Expected to Grow: Should You Buy?Zacks Investment Research • 07/29/25
Stevanato (STVN) Soars 10.0%: Is Further Upside Left in the Stock?Zacks Investment Research • 07/25/25
Stevanato Group Secures €200 Million in Financing from BNL BNP Paribas, Cassa Depositi e Prestiti, and Banco BPM to Fund Ongoing CAPEX Investments in Italy and the U.S.Business Wire • 07/23/25
Stevanato Group to Report Second Quarter 2025 Financial Results on August 5, 2025Business Wire • 07/22/25